Principal Investigator
Wolfgang Kuhn, MD
Quintiles Phase 1
Total Trials
1
As PI
1
Completed
1
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Phase 11
Trial Status
Completed1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
A Study to Assess Safety and Tolerability as Well as Absorption and Excretion of TC-5214 in Medically Stable Elderly Subjects
Elderly Subjects 65 Years and Older, Healthy or With a Stable Disease and Treatment.
Principalinvestigator
Research Network
Collaboration Network
6 collaborators·6 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Quintiles Phase 1
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
2 similar investigators found
Hans A Eriksson, MD
AstraZeneca
2 trials
Shared therapeutic areas:
Elderly Subjects 65 Years and Older, Healthy or With a Stable Disease and Treatment.
Worked with same sponsors:
AstraZeneca
Collaborated on 1 trial
Similarity Score14%
Aslak Rautio, MD
Quintiles Hermelinen
2 trials
Shared therapeutic areas:
Elderly Subjects 65 Years and Older, Healthy or With a Stable Disease and Treatment.
Worked with same sponsors:
AstraZeneca
Collaborated on 1 trial
Similarity Score14%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Study to Assess Safety and Tolerability as Well as Absorption and Excretion of TC-5214 in Medically Stable Elderly Subjects
Elderly Subjects 65 Years and Older, Healthy or With a Stable Disease and Treatment.
All 1 trials loaded